Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) kicked off on Friday, down -1.35% from the previous trading day, before settling in for the closing price of $8.88.
A new trading day began on Monday, with Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) stock price down -2.01% from the previous day of trading, before settling
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Monday, plunged -3.11% from the previous trading day, before settling in for the closing price of $9.66. Within the
As on Wednesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) started slowly as it slid -1.91% to $9.74, before settling in for the price of $9.93 at
On Tuesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was -3.11% drop from the session before settling in for the closing price of $10.29. A 52-week range
A new trading day began on Friday, with Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) stock price up 0.55% from the previous day of trading, before settling
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) flaunted slowness of -1.34% at $11.04, as the Stock market unbolted on Wednesday, before settling in for the price of
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.